Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, TRULIEVE CANNABIS CORP. reported revenue of $1.18B, down 0.4% year over year. Operating margin was 12.1% and net margin -10.3%, on a free-cash-flow margin of 19.4% with capital expenditure at 3.7% of revenue. Every figure is computed directly from TRLV's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $1.18B | 12.1% | -10.3% |
| FY2024 | $1.19B | 8.2% | -13.5% |
| FY2023 | $1.13B | -19.6% | -47.2% |
| FY2022 | $1.22B | 4.1% | -20.7% |
| FY2021 | $932M | 21.9% | 1.9% |
How does TRLV compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.